Thu Mar 28 21:31:50 2024
EVENTS
 FREE
SOFTWARE
INSTITUTE

POLITICS
JOBS
MEMBERS'
CORNER

MAILING
LIST

NYLXS Mailing Lists and Archives
NYLXS Members have a lot to say and share but we don't keep many secrets. Join the Hangout Mailing List and say your peice.

DATE 2020-07-01

HANGOUT

2024-03-28 | 2024-02-28 | 2024-01-28 | 2023-12-28 | 2023-11-28 | 2023-10-28 | 2023-09-28 | 2023-08-28 | 2023-07-28 | 2023-06-28 | 2023-05-28 | 2023-04-28 | 2023-03-28 | 2023-02-28 | 2023-01-28 | 2022-12-28 | 2022-11-28 | 2022-10-28 | 2022-09-28 | 2022-08-28 | 2022-07-28 | 2022-06-28 | 2022-05-28 | 2022-04-28 | 2022-03-28 | 2022-02-28 | 2022-01-28 | 2021-12-28 | 2021-11-28 | 2021-10-28 | 2021-09-28 | 2021-08-28 | 2021-07-28 | 2021-06-28 | 2021-05-28 | 2021-04-28 | 2021-03-28 | 2021-02-28 | 2021-01-28 | 2020-12-28 | 2020-11-28 | 2020-10-28 | 2020-09-28 | 2020-08-28 | 2020-07-28 | 2020-06-28 | 2020-05-28 | 2020-04-28 | 2020-03-28 | 2020-02-28 | 2020-01-28 | 2019-12-28 | 2019-11-28 | 2019-10-28 | 2019-09-28 | 2019-08-28 | 2019-07-28 | 2019-06-28 | 2019-05-28 | 2019-04-28 | 2019-03-28 | 2019-02-28 | 2019-01-28 | 2018-12-28 | 2018-11-28 | 2018-10-28 | 2018-09-28 | 2018-08-28 | 2018-07-28 | 2018-06-28 | 2018-05-28 | 2018-04-28 | 2018-03-28 | 2018-02-28 | 2018-01-28 | 2017-12-28 | 2017-11-28 | 2017-10-28 | 2017-09-28 | 2017-08-28 | 2017-07-28 | 2017-06-28 | 2017-05-28 | 2017-04-28 | 2017-03-28 | 2017-02-28 | 2017-01-28 | 2016-12-28 | 2016-11-28 | 2016-10-28 | 2016-09-28 | 2016-08-28 | 2016-07-28 | 2016-06-28 | 2016-05-28 | 2016-04-28 | 2016-03-28 | 2016-02-28 | 2016-01-28 | 2015-12-28 | 2015-11-28 | 2015-10-28 | 2015-09-28 | 2015-08-28 | 2015-07-28 | 2015-06-28 | 2015-05-28 | 2015-04-28 | 2015-03-28 | 2015-02-28 | 2015-01-28 | 2014-12-28 | 2014-11-28 | 2014-10-28 | 2014-09-28 | 2014-08-28 | 2014-07-28 | 2014-06-28 | 2014-05-28 | 2014-04-28 | 2014-03-28 | 2014-02-28 | 2014-01-28 | 2013-12-28 | 2013-11-28 | 2013-10-28 | 2013-09-28 | 2013-08-28 | 2013-07-28 | 2013-06-28 | 2013-05-28 | 2013-04-28 | 2013-03-28 | 2013-02-28 | 2013-01-28 | 2012-12-28 | 2012-11-28 | 2012-10-28 | 2012-09-28 | 2012-08-28 | 2012-07-28 | 2012-06-28 | 2012-05-28 | 2012-04-28 | 2012-03-28 | 2012-02-28 | 2012-01-28 | 2011-12-28 | 2011-11-28 | 2011-10-28 | 2011-09-28 | 2011-08-28 | 2011-07-28 | 2011-06-28 | 2011-05-28 | 2011-04-28 | 2011-03-28 | 2011-02-28 | 2011-01-28 | 2010-12-28 | 2010-11-28 | 2010-10-28 | 2010-09-28 | 2010-08-28 | 2010-07-28 | 2010-06-28 | 2010-05-28 | 2010-04-28 | 2010-03-28 | 2010-02-28 | 2010-01-28 | 2009-12-28 | 2009-11-28 | 2009-10-28 | 2009-09-28 | 2009-08-28 | 2009-07-28 | 2009-06-28 | 2009-05-28 | 2009-04-28 | 2009-03-28 | 2009-02-28 | 2009-01-28 | 2008-12-28 | 2008-11-28 | 2008-10-28 | 2008-09-28 | 2008-08-28 | 2008-07-28 | 2008-06-28 | 2008-05-28 | 2008-04-28 | 2008-03-28 | 2008-02-28 | 2008-01-28 | 2007-12-28 | 2007-11-28 | 2007-10-28 | 2007-09-28 | 2007-08-28 | 2007-07-28 | 2007-06-28 | 2007-05-28 | 2007-04-28 | 2007-03-28 | 2007-02-28 | 2007-01-28 | 2006-12-28 | 2006-11-28 | 2006-10-28 | 2006-09-28 | 2006-08-28 | 2006-07-28 | 2006-06-28 | 2006-05-28 | 2006-04-28 | 2006-03-28 | 2006-02-28 | 2006-01-28 | 2005-12-28 | 2005-11-28 | 2005-10-28 | 2005-09-28 | 2005-08-28 | 2005-07-28 | 2005-06-28 | 2005-05-28 | 2005-04-28 | 2005-03-28 | 2005-02-28 | 2005-01-28 | 2004-12-28 | 2004-11-28 | 2004-10-28 | 2004-09-28 | 2004-08-28 | 2004-07-28 | 2004-06-28 | 2004-05-28 | 2004-04-28 | 2004-03-28 | 2004-02-28 | 2004-01-28 | 2003-12-28 | 2003-11-28 | 2003-10-28 | 2003-09-28 | 2003-08-28 | 2003-07-28 | 2003-06-28 | 2003-05-28 | 2003-04-28 | 2003-03-28 | 2003-02-28 | 2003-01-28 | 2002-12-28 | 2002-11-28 | 2002-10-28 | 2002-09-28 | 2002-08-28 | 2002-07-28 | 2002-06-28 | 2002-05-28 | 2002-04-28 | 2002-03-28 | 2002-02-28 | 2002-01-28 | 2001-12-28 | 2001-11-28 | 2001-10-28 | 2001-09-28 | 2001-08-28 | 2001-07-28 | 2001-06-28 | 2001-05-28 | 2001-04-28 | 2001-03-28 | 2001-02-28 | 2001-01-28 | 2000-12-28 | 2000-11-28 | 2000-10-28 | 2000-09-28 | 2000-08-28 | 2000-07-28 | 2000-06-28 | 2000-05-28 | 2000-04-28 | 2000-03-28 | 2000-02-28 | 2000-01-28 | 1999-12-28

Key: Value:

Key: Value:

MESSAGE
DATE 2020-07-11
FROM From: "Pharmacy Times Continuing Education - PTCE"
SUBJECT Subject: [Hangout - NYLXS] COVID-19 Live Free CE Webinar!
From hangout-bounces-at-nylxs.com Sun Jul 12 17:15:06 2020
Return-Path:
X-Original-To: archive-at-mrbrklyn.com
Delivered-To: archive-at-mrbrklyn.com
Received: from www2.mrbrklyn.com (www2.mrbrklyn.com [96.57.23.82])
by mrbrklyn.com (Postfix) with ESMTP id 0009E163F7F;
Sun, 12 Jul 2020 17:15:05 -0400 (EDT)
X-Original-To: hangout-at-www2.mrbrklyn.com
Delivered-To: hangout-at-www2.mrbrklyn.com
Received: by mrbrklyn.com (Postfix, from userid 1000)
id 9ADD9163F7A; Sun, 12 Jul 2020 17:15:02 -0400 (EDT)
Resent-From: Ruben Safir
Resent-Date: Sun, 12 Jul 2020 17:15:02 -0400
Resent-Message-ID: <20200712211502.GB32530-at-www2.mrbrklyn.com>
Resent-To: hangout-at-mrbrklyn.com
X-Original-To: ruben-at-mrbrklyn.com
Delivered-To: ruben-at-mrbrklyn.com
Received: from mx42.a.outbound.createsend.com (mx42.a.outbound.createsend.com
[203.55.21.42]) by mrbrklyn.com (Postfix) with ESMTP id E6AC8163F9E
for ; Sat, 11 Jul 2020 17:02:23 -0400 (EDT)
DKIM-Signature: v=1; a=rsa-sha1; c=relaxed/relaxed; s=cm; d=pharmacytimes.org;
h=Subject:From:To:Reply-To:Date:MIME-Version:Content-Type:List-Unsubscribe:Message-ID;
i=ptce-at-pharmacytimes.org; bh=g9+APuFbj/a5wh46H9JmGmB3fCg=;
b=DS7hedhPVC92SamDJWcU19WZuymAqdh9BH5Od/4vBPYKnPajO8jHjkWyZeKejHEfhZ46K6CIWpmO
zyzU7Cw+j2DuqCYlcF16QyVSqoTUXKafrgKyVJQaSUDAKjvJW9K1i2eg1vBji2AxGMOeHedvcer3
coDA/udUncE/tH4CUQg=
DKIM-Signature: v=1; a=rsa-sha1; c=relaxed/relaxed; s=cs2013; d=cmail2.com;
h=Subject:From:To:Reply-To:Date:MIME-Version:Content-Type:List-Unsubscribe:Message-ID;
bh=g9+APuFbj/a5wh46H9JmGmB3fCg=;
b=Olv7n0ibYeFBjQOX48U0wm25HfjIPhkBHlJJBBvy3HD0eV4MnWx0TbEJqrOTBuUaZxQU17l65mB/
VnUfFsUg5vFfhNccB2EWUivJIGhq8qJ1WNOyg8CHFrHSvVo1G2zyyzkXeJOinwQWLvkoyTpm43Ik
BmgRJJu9kcTm+MTINOo=
From: "Pharmacy Times Continuing Education - PTCE"
To: "Ruben Safir"
Date: Sun, 12 Jul 2020 07:02:12 +1000
MIME-Version: 1.0
X-Mailer: Create Send
X-Complaints-To: abuse-at-cmail20.com
X-Feedback-ID: CA1-j-qhjhudt:LI1-j-ekrikh:CL1-j-jruiiu:createSEND
Message-ID:
Subject: [Hangout - NYLXS] COVID-19 Live Free CE Webinar!
X-BeenThere: hangout-at-nylxs.com
X-Mailman-Version: 2.1.30rc1
Precedence: list
List-Id: NYLXS Tech Talk and Politics
List-Unsubscribe: ,

List-Archive:
List-Post:
List-Help:
List-Subscribe: ,

Reply-To: ptce-at-pharmacytimes.org
Content-Type: multipart/mixed; boundary="===============1486874644=="
Errors-To: hangout-bounces-at-nylxs.com
Sender: "Hangout"

--===============1486874644==
Content-Type: multipart/alternative;
boundary="_ebae2282-d0f6-4caa-acaa-c25a1a1bde10_"; charset=utf-8

--_ebae2282-d0f6-4caa-acaa-c25a1a1bde10_
Content-Type: text/plain;
charset="utf-8"
Content-Transfer-Encoding: quoted-printable

No images? Click here https://pharmacytimescontinuingeducation.cmail20.c=
om/t/j-e-qhjhudt-ttqvtdkr-p/

Live Webinar!

Overview of COVID-19: Evolving Investigational Treatment Landscape and Em=
erging Data

Monday, July 20, 2020

7 PM - 8 PM ET

1.0 Live CE Credit

Educational Objectives

Upon completion of this educational activity, participants will be able t=
o:

Examine the burden of the COVID-19 pandemic and potential therapies under=
accelerated development including antivirals and immunomodulatorsExplore=
emerging efficacy and safety data on therapies under investigation for C=
OVID-19, as well as ongoing research in vaccine development

Can't join us for this webinar?

Check out these other live programs!

Managing Therapy

in Heart Failure:

Updates for

Pharmacists

July 14, 2020

A Pharmacist=E2=80=99s Perspective in Hyperkalemia: Improving Clinical Ou=
tcomes With Safe and Effective Treatment Options

July 16, 2020

Click the icon to the left to add this

Live CE Webinar to your calendar!

Pharmacy Times Continuing Education=E2=84=A2 =E2=80=93 an MJH Life Scienc=
es brand

Copyright 2020 =C2=A9 Pharmacy and Healthcare Communications, LLC

2 Clarke Drive | Suite 100 | Cranbury, NJ | 08512 Forward =
https://pharmacytimescontinuingeducation.forwardtomyfriend.com/j-=
ttqvtdkr-EE17CB78-qhjhudt-l-x Preferences https:=
//pharmacytimescontinuingeducation.updatemyprofile.com/j-qhjhudt-=
EE17CB78-ttqvtdkr-m | Unsubscribe https://pharmacytimesco=
ntinuingeducation.cmail20.com/t/j-u-qhjhudt-ttqvtdkr-c/

--_ebae2282-d0f6-4caa-acaa-c25a1a1bde10_
Content-Type: text/html;
charset="utf-8"
Content-Transfer-Encoding: quoted-printable

ww.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">99/xhtml">
-8">

E=3Dedge">



=20
t:400,700,400italic|Roboto:400,700,400italic,700italic" rel=3D"stylesheet=
" type=3D"text/css">


ize-adjust: 100%;">
eight:0;overflow:hidden;font-size:0;">Overview of COVID-19: Evolving Inve=
stigational Treatment Landscape and Emerging Data‌ ‌ =
‌ ‌ ‌ ‌ ‌ ‌ &=
zwnj; ‌ ‌ ‌ ‌ ‌ &z=
wnj; ‌ ‌ ‌ ‌ ‌ &zw=
nj; ‌ ‌ ‌ ‌ ‌ &zwn=
j; ‌ ‌ ‌ ‌ ‌ &zwnj=
; ‌ ‌ ‌ ‌ ‌ ‌=
 ‌ ‌ ‌ ‌ ‌ ‌&=
nbsp;‌ ‌ ‌ ‌ ‌ ‌&n=
bsp;‌ ‌ ‌ ‌ ‌ ‌&nb=
sp;‌ ‌ ‌ ‌ ‌ ‌&nbs=
p;‌ ‌ ‌ ‌ ‌ ‌ =
;‌ ‌ ‌ ‌ ‌ ‌ =
‌ ‌ ‌ ‌ ‌ ‌ &=
zwnj; ‌ ‌ ‌ ‌ ‌ &z=
wnj; ‌ ‌ ‌ ‌ ‌ &zw=
nj; ‌ ‌ ‌ ‌ ‌ &zwn=
j; ‌ ‌ ‌ ‌ ‌ &zwnj=
; ‌ ‌ ‌ ‌ ‌ ‌=
 ‌ ‌ ‌ ‌ ‌ ‌&=
nbsp;‌ ‌ ‌ ‌ ‌ ‌&n=
bsp;‌ ‌ ‌ ‌ ‌ ‌&nb=
sp;‌ ‌ ‌ ‌ ‌ ‌&nbs=
p;‌ ‌ ‌ ‌ ‌ ‌ =
;‌ ‌ ‌ ‌ ‌ ‌ =
‌ ‌ ‌ ‌ ‌ ‌ &=
zwnj; ‌ ‌ ‌ ‌ ‌ &z=
wnj; ‌ ‌ ‌ ‌ ‌ &zw=
nj; ‌ ‌ ‌ ‌ ‌ &zwn=
j; ‌ ‌ ‌ ‌ ‌ &zwnj=
; ‌ ‌ ‌ ‌ ‌ ‌=
 ‌ ‌ ‌ ‌ ‌ ‌&=
nbsp;‌ ‌ ‌ ‌ ‌ ‌&n=
bsp;‌ ‌ ‌ ‌ ‌ ‌&nb=
sp;‌ ‌ ‌ ‌ ‌ ‌&nbs=
p;‌ ‌ ‌ ‌ ‌ ‌ =
;‌ ‌ ‌ ‌ ‌ ‌ =
‌ ‌ ‌ ‌ ‌ ‌ &=
zwnj; ‌ ‌ ‌ ‌ ‌ &z=
wnj; ‌ ‌ ‌ ‌ ‌ &zw=
nj; ‌ ‌ ‌ ‌ ‌ &zwn=
j; ‌ ‌ ‌ ‌ 

out: fixed;min-width: 320px;width: 100%;background-color: #fff;" cellpadd=
ing=3D"0" cellspacing=3D"0" role=3D"presentation">


;min-width: 280px; width: 280px;width: calc(28000% - 167440px);">
00%;">

ft;font-size: 12px;line-height: 19px;max-width: 280px;min-width: 140px; w=
idth: 140px;width: calc(14000% - 78120px);padding: 10px 0 5px 0;color: #0=
00;font-family: Montserrat,DejaVu Sans,Verdana,sans-serif;">
=20


left;font-size: 12px;line-height: 19px;max-width: 280px;min-width: 139px=
; width: 139px;width: calc(14100% - 78680px);padding: 10px 0 5px 0;text-a=
lign: right;color: #000;font-family: Montserrat,DejaVu Sans,Verdana,sans-=
serif;">

No images? style=3D"text-decoration: underline;transition: opacity 0.1s ease-in;colo=
r: #000;" href=3D"https://pharmacytimescontinuingeducation.cmail20.com/t/=
j-e-qhjhudt-ttqvtdkr-h/">Click here






n-width: 320px; width: 320px;width: calc(28000% - 167400px);" id=3D"emb-e=
mail-header-container">







idth: 600px;min-width: 320px; width: 320px;width: calc(28000% - 167400px)=
;overflow-wrap: break-word;word-wrap: break-word;word-break: break-word;"=
>
;display: table;width: 100%;">

ont-size: 16px;line-height: 24px;font-family: Roboto,Tahoma,sans-serif;">=

=20

ize: 1px;"> 


=20





=20

idth: 600px;min-width: 320px; width: 320px;width: calc(28000% - 167400px)=
;overflow-wrap: break-word;word-wrap: break-word;word-break: break-word;"=
>
;display: table;width: 100%;">

ont-size: 16px;line-height: 24px;font-family: Roboto,Tahoma,sans-serif;">=

=20

size: 1px;"> 


=20





=20
o-repeat url(http://i1.cmail20.com/ei/j/88/91D/0BF/041230/csfinal/PTCE_CO=
VID_Email_071020v1.png) #ffffff;background-position: 19% 10%;background-i=
mage: url(http://i1.cmail20.com/ei/j/88/91D/0BF/041230/csfinal/PTCE_COVID=
_Email_071020v1.png);background-repeat: no-repeat;background-size: cover;=
">
idth: 600px;min-width: 320px; width: 320px;width: calc(28000% - 167400px)=
;overflow-wrap: break-word;word-wrap: break-word;word-break: break-word;"=
>
;display: table;width: 100%;">

ont-size: 16px;line-height: 24px;font-family: Roboto,Tahoma,sans-serif;">=

=20

size: 1px;"> 


=20

ize: 1px;"> 


=20

rtical-align: middle;">

ont-family: montserrat,dejavu sans,verdana,sans-serif;font-size: 16px;lin=
e-height: 24px;text-align: center;" lang=3D"x-size-16">t-montserrat">Live Webinar!>




=20

rtical-align: middle;">

ont-family: montserrat,dejavu sans,verdana,sans-serif;font-size: 17px;lin=
e-height: 26px;text-align: center;" lang=3D"x-size-20">t-montserrat">Overview of COVID-19:=
Evolving Investigational Treatment Landscape and Emerging Data
<=
/span>




=20

rtical-align: middle;">

rrat,dejavu sans,verdana,sans-serif;text-align: center;">ont-montserrat">Monday, July 20, 2020

7 PM - 8 PM ET

1.0 Live CE Credit




=20

=20
op: 20px;">
ize: 1px;"> 


=20





=20

idth: 600px;min-width: 320px; width: 320px;width: calc(28000% - 167400px)=
;overflow-wrap: break-word;word-wrap: break-word;word-break: break-word;"=
>
;display: table;width: 100%;">

ont-size: 16px;line-height: 24px;font-family: Roboto,Tahoma,sans-serif;">=

=20

size: 1px;"> 


=20





=20

idth: 600px;min-width: 320px; width: 320px;width: calc(28000% - 167400px)=
;overflow-wrap: break-word;word-wrap: break-word;word-break: break-word;"=
>
;display: table;width: 100%;">

ont-size: 16px;line-height: 24px;font-family: Roboto,Tahoma,sans-serif;">=

=20

size: 1px;"> 


=20
mal;line-height: 19px;" align=3D"center">
;max-width: 209px;" alt=3D"" width=3D"209" src=3D"http://i2.cmail20.com/e=
i/j/88/91D/0BF/041230/csfinal/DTlogo-990b6d0000028a3c.png">

=20
op: 20px;">
rtical-align: middle;">

ont-family: montserrat,dejavu sans,verdana,sans-serif;font-size: 15px;lin=
e-height: 23px;text-align: center;" lang=3D"x-size-15">t-montserrat">Educational Objective=
s


Upon completion of this educational activity, participants will be ab=
le to:




=20

rtical-align: middle;">
    padding: 0;list-style-type: disc;">
  • top: 0;Margin-bottom: 0;Margin-left: 0;font-family: montserrat,dejavu san=
    s,verdana,sans-serif;font-size: 15px;line-height: 23px;" lang=3D"x-size-1=
    5">Examine =
    the burden of the COVID-19 pandemic and potential therapies under acceler=
    ated development including antivirals and immunomodulators
    <=
    /li>
  • left: 0;font-family: montserrat,dejavu sans,verdana,sans-serif;font-size:=
    15px;line-height: 23px;" lang=3D"x-size-15">at">Explore emerging efficacy and safety da=
    ta on therapies under investigation for COVID-19, as well as ongoing rese=
    arch in vaccine=20
    development



=20

=20
op: 20px;">
ize: 1px;"> 


=20





=20
ize: 8px;"> 

=20

idth: 600px;min-width: 320px; width: 320px;width: calc(28000% - 167400px)=
;overflow-wrap: break-word;word-wrap: break-word;word-break: break-word;"=
>
;display: table;width: 100%;">

ont-size: 16px;line-height: 24px;font-family: Roboto,Tahoma,sans-serif;">=

=20

size: 1px;"> 


=20

rtical-align: middle;">

rrat,dejavu sans,verdana,sans-serif;text-align: center;">ont-montserrat">Can't join us for this webi=
nar?

Check out these other live programs!




=20

ize: 1px;"> 


=20





=20

idth: 600px;min-width: 320px; width: 320px;width: calc(28000% - 167400px)=
;overflow-wrap: break-word;word-wrap: break-word;word-break: break-word;"=
>
;display: table;width: 100%;">

ont-size: 16px;line-height: 24px;font-family: Roboto,Tahoma,sans-serif;ma=
x-width: 320px;min-width: 300px; width: 320px;width: calc(12300px - 2000%=
);Float: left;">
=20

rtical-align: middle;">

ont-family: montserrat,dejavu sans,verdana,sans-serif;font-size: 15px;lin=
e-height: 23px;text-align: center;" lang=3D"x-size-15">t-montserrat">Managing Therapy

in Heart Failure:

Updates for

Pharmacists




July 14, 2020




=20

=20
op: 20px;">
ize: 1px;"> 


=20


ont-size: 16px;line-height: 24px;font-family: Roboto,Tahoma,sans-serif;ma=
x-width: 320px;min-width: 300px; width: 320px;width: calc(12300px - 2000%=
);Float: left;">
=20

rtical-align: middle;">

ont-family: montserrat,dejavu sans,verdana,sans-serif;font-size: 15px;lin=
e-height: 23px;text-align: center;" lang=3D"x-size-15">t-montserrat">A Pharmacist’s =
Perspective in Hyperkalemia: Improving Clinical Outcomes With Safe and Ef=
fective Treatment Options




July 16, 2020




=20

=20
op: 20px;">
ize: 1px;"> 


=20





=20

idth: 600px;min-width: 320px; width: 320px;width: calc(28000% - 167400px)=
;overflow-wrap: break-word;word-wrap: break-word;word-break: break-word;"=
>
;display: table;width: 100%;">

ont-size: 16px;line-height: 24px;font-family: Roboto,Tahoma,sans-serif;">=

=20

size: 1px;"> 


=20





=20

0px;min-width: 320px; width: 320px;width: calc(28000% - 167400px);overflo=
w-wrap: break-word;word-wrap: break-word;word-break: break-word;">
;display: table;width: 100%;">



000;font-size: 16px;line-height: 24px;font-family: Roboto,Tahoma,sans-ser=
if;Float: left;max-width: 400px;min-width: 320px; width: 320px;width: cal=
c(8000% - 47600px);">
=20

size: 1px;"> 


=20

rtical-align: middle;">

t,dejavu sans,verdana,sans-serif;text-align: center;">-montserrat">Click the icon to the left to =
add this

Live CE Webinar to your calendar!




=20





=20
size: 20px;"> 

=20
auto;max-width: 600px;min-width: 320px; width: 320px;width: calc(28000% -=
167400px);overflow-wrap: break-word;word-wrap: break-word;word-break: br=
eak-word;">
isplay: table;width: 100%;background-color: #ffffff;">

t-size: 16px;line-height: 24px;font-family: Roboto,Tahoma,sans-serif;">
=20
mal;line-height: 19px;" align=3D"center">
;max-width: 600px;" alt=3D"" width=3D"600" src=3D"http://i7.cmail20.com/e=
i/j/88/91D/0BF/041230/csfinal/UpdatedPTCE_Rebrand_EmailBanner_042420v2-99=
00000000079e3c.jpg">

=20




=20
size: 20px;"> 

=20

idth: 600px;min-width: 320px; width: 320px;width: calc(28000% - 167400px)=
;overflow-wrap: break-word;word-wrap: break-word;word-break: break-word;"=
>
;display: table;width: 100%;">

ont-size: 16px;line-height: 24px;font-family: Roboto,Tahoma,sans-serif;">=

=20

ize: 1px;"> 


=20





=20
size: 20px;"> 

=20
=20

max-width: 600px;min-width: 320px; width: 320px;width: calc(28000% - 1674=
00px);overflow-wrap: break-word;word-wrap: break-word;word-break: break-w=
ord;">
;display: table;width: 100%;">

e: 12px;line-height: 19px;color: #000;font-family: Montserrat,DejaVu Sans=
,Verdana,sans-serif;Float: left;max-width: 400px;min-width: 320px; width:=
320px;width: calc(8000% - 47600px);">
op: 10px;Margin-bottom: 10px;">
=20

Pharmacy Times Continuing Education™ –=
an MJH Life Sciences brand

Copyright 2020 © Pharmacy and Healthcare Communications, LLC

2 Clarke Drive | Suite 100 | Cranbury, NJ | 08512


p: 18px;">
=20









o;max-width: 600px;min-width: 320px; width: 320px;width: calc(28000% - 16=
7400px);overflow-wrap: break-word;word-wrap: break-word;word-break: break=
-word;">
;display: table;width: 100%;">

px;line-height: 19px;color: #000;font-family: Montserrat,DejaVu Sans,Verd=
ana,sans-serif;">
op: 10px;Margin-bottom: 10px;">

: opacity 0.1s ease-in;color: #000;" href=3D"https://pharmacytimescontinu=
ingeducation.updatemyprofile.com/j-qhjhudt-EE17CB78-=
ttqvtdkr-u" lang=3D"en">Preferences
  |  
style=3D"text-decoration: underline;transition: opacity 0.1s ease-in;col=
or: #000;" href=3D"https://pharmacytimescontinuingeducation.cmail20.com/t=
/j-u-qhjhudt-ttqvtdkr-o/">Unsubscribe







 


rtant;display: block !important;height: 1px !important;width: 1px !import=
ant;border: 0 !important;margin: 0 !important;padding: 0 !important;" src=
=3D"https://pharmacytimescontinuingeducation.cmail20.com/t/j-o-qhjhudt-=
ttqvtdkr/o.gif" width=3D"1" height=3D"1" border=3D"0" alt=3D"">
=




--_ebae2282-d0f6-4caa-acaa-c25a1a1bde10_--

--===============1486874644==
Content-Type: text/plain; charset="us-ascii"
MIME-Version: 1.0
Content-Transfer-Encoding: 7bit
Content-Disposition: inline

_______________________________________________
Hangout mailing list
Hangout-at-nylxs.com
http://lists.mrbrklyn.com/mailman/listinfo/hangout

--===============1486874644==--

--===============1486874644==
Content-Type: multipart/alternative;
boundary="_ebae2282-d0f6-4caa-acaa-c25a1a1bde10_"; charset=utf-8

--_ebae2282-d0f6-4caa-acaa-c25a1a1bde10_
Content-Type: text/plain;
charset="utf-8"
Content-Transfer-Encoding: quoted-printable

No images? Click here https://pharmacytimescontinuingeducation.cmail20.c=
om/t/j-e-qhjhudt-ttqvtdkr-p/

Live Webinar!

Overview of COVID-19: Evolving Investigational Treatment Landscape and Em=
erging Data

Monday, July 20, 2020

7 PM - 8 PM ET

1.0 Live CE Credit

Educational Objectives

Upon completion of this educational activity, participants will be able t=
o:

Examine the burden of the COVID-19 pandemic and potential therapies under=
accelerated development including antivirals and immunomodulatorsExplore=
emerging efficacy and safety data on therapies under investigation for C=
OVID-19, as well as ongoing research in vaccine development

Can't join us for this webinar?

Check out these other live programs!

Managing Therapy

in Heart Failure:

Updates for

Pharmacists

July 14, 2020

A Pharmacist=E2=80=99s Perspective in Hyperkalemia: Improving Clinical Ou=
tcomes With Safe and Effective Treatment Options

July 16, 2020

Click the icon to the left to add this

Live CE Webinar to your calendar!

Pharmacy Times Continuing Education=E2=84=A2 =E2=80=93 an MJH Life Scienc=
es brand

Copyright 2020 =C2=A9 Pharmacy and Healthcare Communications, LLC

2 Clarke Drive | Suite 100 | Cranbury, NJ | 08512 Forward =
https://pharmacytimescontinuingeducation.forwardtomyfriend.com/j-=
ttqvtdkr-EE17CB78-qhjhudt-l-x Preferences https:=
//pharmacytimescontinuingeducation.updatemyprofile.com/j-qhjhudt-=
EE17CB78-ttqvtdkr-m | Unsubscribe https://pharmacytimesco=
ntinuingeducation.cmail20.com/t/j-u-qhjhudt-ttqvtdkr-c/

--_ebae2282-d0f6-4caa-acaa-c25a1a1bde10_
Content-Type: text/html;
charset="utf-8"
Content-Transfer-Encoding: quoted-printable

ww.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">99/xhtml">
-8">

E=3Dedge">



=20
t:400,700,400italic|Roboto:400,700,400italic,700italic" rel=3D"stylesheet=
" type=3D"text/css">


ize-adjust: 100%;">
eight:0;overflow:hidden;font-size:0;">Overview of COVID-19: Evolving Inve=
stigational Treatment Landscape and Emerging Data‌ ‌ =
‌ ‌ ‌ ‌ ‌ ‌ &=
zwnj; ‌ ‌ ‌ ‌ ‌ &z=
wnj; ‌ ‌ ‌ ‌ ‌ &zw=
nj; ‌ ‌ ‌ ‌ ‌ &zwn=
j; ‌ ‌ ‌ ‌ ‌ &zwnj=
; ‌ ‌ ‌ ‌ ‌ ‌=
 ‌ ‌ ‌ ‌ ‌ ‌&=
nbsp;‌ ‌ ‌ ‌ ‌ ‌&n=
bsp;‌ ‌ ‌ ‌ ‌ ‌&nb=
sp;‌ ‌ ‌ ‌ ‌ ‌&nbs=
p;‌ ‌ ‌ ‌ ‌ ‌ =
;‌ ‌ ‌ ‌ ‌ ‌ =
‌ ‌ ‌ ‌ ‌ ‌ &=
zwnj; ‌ ‌ ‌ ‌ ‌ &z=
wnj; ‌ ‌ ‌ ‌ ‌ &zw=
nj; ‌ ‌ ‌ ‌ ‌ &zwn=
j; ‌ ‌ ‌ ‌ ‌ &zwnj=
; ‌ ‌ ‌ ‌ ‌ ‌=
 ‌ ‌ ‌ ‌ ‌ ‌&=
nbsp;‌ ‌ ‌ ‌ ‌ ‌&n=
bsp;‌ ‌ ‌ ‌ ‌ ‌&nb=
sp;‌ ‌ ‌ ‌ ‌ ‌&nbs=
p;‌ ‌ ‌ ‌ ‌ ‌ =
;‌ ‌ ‌ ‌ ‌ ‌ =
‌ ‌ ‌ ‌ ‌ ‌ &=
zwnj; ‌ ‌ ‌ ‌ ‌ &z=
wnj; ‌ ‌ ‌ ‌ ‌ &zw=
nj; ‌ ‌ ‌ ‌ ‌ &zwn=
j; ‌ ‌ ‌ ‌ ‌ &zwnj=
; ‌ ‌ ‌ ‌ ‌ ‌=
 ‌ ‌ ‌ ‌ ‌ ‌&=
nbsp;‌ ‌ ‌ ‌ ‌ ‌&n=
bsp;‌ ‌ ‌ ‌ ‌ ‌&nb=
sp;‌ ‌ ‌ ‌ ‌ ‌&nbs=
p;‌ ‌ ‌ ‌ ‌ ‌ =
;‌ ‌ ‌ ‌ ‌ ‌ =
‌ ‌ ‌ ‌ ‌ ‌ &=
zwnj; ‌ ‌ ‌ ‌ ‌ &z=
wnj; ‌ ‌ ‌ ‌ ‌ &zw=
nj; ‌ ‌ ‌ ‌ ‌ &zwn=
j; ‌ ‌ ‌ ‌ 

out: fixed;min-width: 320px;width: 100%;background-color: #fff;" cellpadd=
ing=3D"0" cellspacing=3D"0" role=3D"presentation">


;min-width: 280px; width: 280px;width: calc(28000% - 167440px);">
00%;">

ft;font-size: 12px;line-height: 19px;max-width: 280px;min-width: 140px; w=
idth: 140px;width: calc(14000% - 78120px);padding: 10px 0 5px 0;color: #0=
00;font-family: Montserrat,DejaVu Sans,Verdana,sans-serif;">
=20


left;font-size: 12px;line-height: 19px;max-width: 280px;min-width: 139px=
; width: 139px;width: calc(14100% - 78680px);padding: 10px 0 5px 0;text-a=
lign: right;color: #000;font-family: Montserrat,DejaVu Sans,Verdana,sans-=
serif;">

No images? style=3D"text-decoration: underline;transition: opacity 0.1s ease-in;colo=
r: #000;" href=3D"https://pharmacytimescontinuingeducation.cmail20.com/t/=
j-e-qhjhudt-ttqvtdkr-h/">Click here






n-width: 320px; width: 320px;width: calc(28000% - 167400px);" id=3D"emb-e=
mail-header-container">







idth: 600px;min-width: 320px; width: 320px;width: calc(28000% - 167400px)=
;overflow-wrap: break-word;word-wrap: break-word;word-break: break-word;"=
>
;display: table;width: 100%;">

ont-size: 16px;line-height: 24px;font-family: Roboto,Tahoma,sans-serif;">=

=20

ize: 1px;"> 


=20





=20

idth: 600px;min-width: 320px; width: 320px;width: calc(28000% - 167400px)=
;overflow-wrap: break-word;word-wrap: break-word;word-break: break-word;"=
>
;display: table;width: 100%;">

ont-size: 16px;line-height: 24px;font-family: Roboto,Tahoma,sans-serif;">=

=20

size: 1px;"> 


=20





=20
o-repeat url(http://i1.cmail20.com/ei/j/88/91D/0BF/041230/csfinal/PTCE_CO=
VID_Email_071020v1.png) #ffffff;background-position: 19% 10%;background-i=
mage: url(http://i1.cmail20.com/ei/j/88/91D/0BF/041230/csfinal/PTCE_COVID=
_Email_071020v1.png);background-repeat: no-repeat;background-size: cover;=
">
idth: 600px;min-width: 320px; width: 320px;width: calc(28000% - 167400px)=
;overflow-wrap: break-word;word-wrap: break-word;word-break: break-word;"=
>
;display: table;width: 100%;">

ont-size: 16px;line-height: 24px;font-family: Roboto,Tahoma,sans-serif;">=

=20

size: 1px;"> 


=20

ize: 1px;"> 


=20

rtical-align: middle;">

ont-family: montserrat,dejavu sans,verdana,sans-serif;font-size: 16px;lin=
e-height: 24px;text-align: center;" lang=3D"x-size-16">t-montserrat">Live Webinar!>




=20

rtical-align: middle;">

ont-family: montserrat,dejavu sans,verdana,sans-serif;font-size: 17px;lin=
e-height: 26px;text-align: center;" lang=3D"x-size-20">t-montserrat">Overview of COVID-19:=
Evolving Investigational Treatment Landscape and Emerging Data
<=
/span>




=20

rtical-align: middle;">

rrat,dejavu sans,verdana,sans-serif;text-align: center;">ont-montserrat">Monday, July 20, 2020

7 PM - 8 PM ET

1.0 Live CE Credit




=20

=20
op: 20px;">
ize: 1px;"> 


=20





=20

idth: 600px;min-width: 320px; width: 320px;width: calc(28000% - 167400px)=
;overflow-wrap: break-word;word-wrap: break-word;word-break: break-word;"=
>
;display: table;width: 100%;">

ont-size: 16px;line-height: 24px;font-family: Roboto,Tahoma,sans-serif;">=

=20

size: 1px;"> 


=20





=20

idth: 600px;min-width: 320px; width: 320px;width: calc(28000% - 167400px)=
;overflow-wrap: break-word;word-wrap: break-word;word-break: break-word;"=
>
;display: table;width: 100%;">

ont-size: 16px;line-height: 24px;font-family: Roboto,Tahoma,sans-serif;">=

=20

size: 1px;"> 


=20
mal;line-height: 19px;" align=3D"center">
;max-width: 209px;" alt=3D"" width=3D"209" src=3D"http://i2.cmail20.com/e=
i/j/88/91D/0BF/041230/csfinal/DTlogo-990b6d0000028a3c.png">

=20
op: 20px;">
rtical-align: middle;">

ont-family: montserrat,dejavu sans,verdana,sans-serif;font-size: 15px;lin=
e-height: 23px;text-align: center;" lang=3D"x-size-15">t-montserrat">Educational Objective=
s


Upon completion of this educational activity, participants will be ab=
le to:




=20

rtical-align: middle;">
    padding: 0;list-style-type: disc;">
  • top: 0;Margin-bottom: 0;Margin-left: 0;font-family: montserrat,dejavu san=
    s,verdana,sans-serif;font-size: 15px;line-height: 23px;" lang=3D"x-size-1=
    5">Examine =
    the burden of the COVID-19 pandemic and potential therapies under acceler=
    ated development including antivirals and immunomodulators
    <=
    /li>
  • left: 0;font-family: montserrat,dejavu sans,verdana,sans-serif;font-size:=
    15px;line-height: 23px;" lang=3D"x-size-15">at">Explore emerging efficacy and safety da=
    ta on therapies under investigation for COVID-19, as well as ongoing rese=
    arch in vaccine=20
    development



=20

=20
op: 20px;">
ize: 1px;"> 


=20





=20
ize: 8px;"> 

=20

idth: 600px;min-width: 320px; width: 320px;width: calc(28000% - 167400px)=
;overflow-wrap: break-word;word-wrap: break-word;word-break: break-word;"=
>
;display: table;width: 100%;">

ont-size: 16px;line-height: 24px;font-family: Roboto,Tahoma,sans-serif;">=

=20

size: 1px;"> 


=20

rtical-align: middle;">

rrat,dejavu sans,verdana,sans-serif;text-align: center;">ont-montserrat">Can't join us for this webi=
nar?

Check out these other live programs!




=20

ize: 1px;"> 


=20





=20

idth: 600px;min-width: 320px; width: 320px;width: calc(28000% - 167400px)=
;overflow-wrap: break-word;word-wrap: break-word;word-break: break-word;"=
>
;display: table;width: 100%;">

ont-size: 16px;line-height: 24px;font-family: Roboto,Tahoma,sans-serif;ma=
x-width: 320px;min-width: 300px; width: 320px;width: calc(12300px - 2000%=
);Float: left;">
=20

rtical-align: middle;">

ont-family: montserrat,dejavu sans,verdana,sans-serif;font-size: 15px;lin=
e-height: 23px;text-align: center;" lang=3D"x-size-15">t-montserrat">Managing Therapy

in Heart Failure:

Updates for

Pharmacists




July 14, 2020




=20

=20
op: 20px;">
ize: 1px;"> 


=20


ont-size: 16px;line-height: 24px;font-family: Roboto,Tahoma,sans-serif;ma=
x-width: 320px;min-width: 300px; width: 320px;width: calc(12300px - 2000%=
);Float: left;">
=20

rtical-align: middle;">

ont-family: montserrat,dejavu sans,verdana,sans-serif;font-size: 15px;lin=
e-height: 23px;text-align: center;" lang=3D"x-size-15">t-montserrat">A Pharmacist’s =
Perspective in Hyperkalemia: Improving Clinical Outcomes With Safe and Ef=
fective Treatment Options




July 16, 2020




=20

=20
op: 20px;">
ize: 1px;"> 


=20





=20

idth: 600px;min-width: 320px; width: 320px;width: calc(28000% - 167400px)=
;overflow-wrap: break-word;word-wrap: break-word;word-break: break-word;"=
>
;display: table;width: 100%;">

ont-size: 16px;line-height: 24px;font-family: Roboto,Tahoma,sans-serif;">=

=20

size: 1px;"> 


=20





=20

0px;min-width: 320px; width: 320px;width: calc(28000% - 167400px);overflo=
w-wrap: break-word;word-wrap: break-word;word-break: break-word;">
;display: table;width: 100%;">



000;font-size: 16px;line-height: 24px;font-family: Roboto,Tahoma,sans-ser=
if;Float: left;max-width: 400px;min-width: 320px; width: 320px;width: cal=
c(8000% - 47600px);">
=20

size: 1px;"> 


=20

rtical-align: middle;">

t,dejavu sans,verdana,sans-serif;text-align: center;">-montserrat">Click the icon to the left to =
add this

Live CE Webinar to your calendar!




=20





=20
size: 20px;"> 

=20
auto;max-width: 600px;min-width: 320px; width: 320px;width: calc(28000% -=
167400px);overflow-wrap: break-word;word-wrap: break-word;word-break: br=
eak-word;">
isplay: table;width: 100%;background-color: #ffffff;">

t-size: 16px;line-height: 24px;font-family: Roboto,Tahoma,sans-serif;">
=20
mal;line-height: 19px;" align=3D"center">
;max-width: 600px;" alt=3D"" width=3D"600" src=3D"http://i7.cmail20.com/e=
i/j/88/91D/0BF/041230/csfinal/UpdatedPTCE_Rebrand_EmailBanner_042420v2-99=
00000000079e3c.jpg">

=20




=20
size: 20px;"> 

=20

idth: 600px;min-width: 320px; width: 320px;width: calc(28000% - 167400px)=
;overflow-wrap: break-word;word-wrap: break-word;word-break: break-word;"=
>
;display: table;width: 100%;">

ont-size: 16px;line-height: 24px;font-family: Roboto,Tahoma,sans-serif;">=

=20

ize: 1px;"> 


=20





=20
size: 20px;"> 

=20
=20

max-width: 600px;min-width: 320px; width: 320px;width: calc(28000% - 1674=
00px);overflow-wrap: break-word;word-wrap: break-word;word-break: break-w=
ord;">
;display: table;width: 100%;">

e: 12px;line-height: 19px;color: #000;font-family: Montserrat,DejaVu Sans=
,Verdana,sans-serif;Float: left;max-width: 400px;min-width: 320px; width:=
320px;width: calc(8000% - 47600px);">
op: 10px;Margin-bottom: 10px;">
=20

Pharmacy Times Continuing Education™ –=
an MJH Life Sciences brand

Copyright 2020 © Pharmacy and Healthcare Communications, LLC

2 Clarke Drive | Suite 100 | Cranbury, NJ | 08512


p: 18px;">
=20









o;max-width: 600px;min-width: 320px; width: 320px;width: calc(28000% - 16=
7400px);overflow-wrap: break-word;word-wrap: break-word;word-break: break=
-word;">
;display: table;width: 100%;">

px;line-height: 19px;color: #000;font-family: Montserrat,DejaVu Sans,Verd=
ana,sans-serif;">
op: 10px;Margin-bottom: 10px;">

: opacity 0.1s ease-in;color: #000;" href=3D"https://pharmacytimescontinu=
ingeducation.updatemyprofile.com/j-qhjhudt-EE17CB78-=
ttqvtdkr-u" lang=3D"en">Preferences
  |  
style=3D"text-decoration: underline;transition: opacity 0.1s ease-in;col=
or: #000;" href=3D"https://pharmacytimescontinuingeducation.cmail20.com/t=
/j-u-qhjhudt-ttqvtdkr-o/">Unsubscribe







 


rtant;display: block !important;height: 1px !important;width: 1px !import=
ant;border: 0 !important;margin: 0 !important;padding: 0 !important;" src=
=3D"https://pharmacytimescontinuingeducation.cmail20.com/t/j-o-qhjhudt-=
ttqvtdkr/o.gif" width=3D"1" height=3D"1" border=3D"0" alt=3D"">
=




--_ebae2282-d0f6-4caa-acaa-c25a1a1bde10_--

--===============1486874644==
Content-Type: text/plain; charset="us-ascii"
MIME-Version: 1.0
Content-Transfer-Encoding: 7bit
Content-Disposition: inline

_______________________________________________
Hangout mailing list
Hangout-at-nylxs.com
http://lists.mrbrklyn.com/mailman/listinfo/hangout

--===============1486874644==--

  1. 2020-07-01 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] Childhood Culture
  2. 2020-07-01 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] Lot s of Protesting and no evidence of COVID
  3. 2020-07-02 From: "American Museum of Natural History" <learn-at-amnh.org> Subject: [Hangout - NYLXS] There Are Only a Few Days Left to Register for
  4. 2020-07-02 From: "Canarsie Courier" <emailsentby-at-icontactmail.com> Subject: [Hangout - NYLXS] Inside This Week's Edition of the Canarsie Courier
  5. 2020-07-02 Rabbinical Seminary of America <info-at-rsa30k.com> Subject: [Hangout - NYLXS] Tonight is the Deadline to win $30,000!
  6. 2020-07-02 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] nothing to worry about... just keep using the
  7. 2020-07-02 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] Real News Slips Past Us
  8. 2020-07-02 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] A ray of hope about the Police
  9. 2020-07-02 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] Bars and resturants not reopening... maybe ever..
  10. 2020-07-02 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] ICU treatment for COVID-19 is still under debate
  11. 2020-07-03 Yusif Suleiman <yusifsuleiman-at-hotmail.com> Subject: [Hangout - NYLXS] [Health] GNU Health test-run in production
  12. 2020-07-04 Edgar Hagenbichler <edgar.hagenbichler-at-hagenbichler.at> Re: [Hangout - NYLXS] [Health] GNU Health test-run in production
  13. 2020-07-06 Yusif Suleiman <yusifsuleiman-at-hotmail.com> Re: [Hangout - NYLXS] [Health] GNU Health test-run in production
  14. 2020-07-06 Javier via artix-general <artix-general-at-artixlinux.org> Re: [Hangout - NYLXS] [artix-general] [s6] system not
  15. 2020-07-06 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] Putting the pressure on China
  16. 2020-07-06 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] access to network drive - denies to root?
  17. 2020-07-06 Chris Cromer via artix-general <artix-general-at-artixlinux.org> Re: [Hangout - NYLXS] [artix-general] access to network drive -
  18. 2020-07-07 Ruben Safir <ruben-at-mrbrklyn.com> Re: [Hangout - NYLXS] [artix-general] access to network drive -
  19. 2020-07-05 Kian Kasad via artix-general <artix-general-at-artixlinux.org> Subject: [Hangout - NYLXS] [artix-general] how to create distcc-runit package
  20. 2020-07-07 Ruben Safir <ruben-at-mrbrklyn.com> Re: [Hangout - NYLXS] [artix-general] access to network drive -
  21. 2020-07-07 Chris Cromer via artix-general <artix-general-at-artixlinux.org> Re: [Hangout - NYLXS] [artix-general] access to network drive -
  22. 2020-07-07 NYOUG <execdir-at-nyoug.org> Subject: [Hangout - NYLXS] Upcoming Events for Oracle Professionals
  23. 2020-07-07 Dudemanguy via artix-general <artix-general-at-artixlinux.org> Re: [Hangout - NYLXS] [artix-general] [s6] system not
  24. 2020-07-07 Dudemanguy via artix-general <artix-general-at-artixlinux.org> Re: [Hangout - NYLXS] [artix-general] how to create distcc-runit
  25. 2020-07-08 From: "[RSS/Feed] nixCraft: Linux Tips, Hacks, Tutorials, Subject: [Hangout - NYLXS] nixCraft Linux / UNIX Newsletter
  26. 2020-07-08 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] making up news on a slow newws day
  27. 2020-07-08 Ruben Safir <mrbrklyn-at-panix.com> Subject: [Hangout - NYLXS] Time Off
  28. 2020-07-08 Ruben Safir <mrbrklyn-at-panix.com> Subject: [Hangout - NYLXS] No Conflict of Interest there...
  29. 2020-07-08 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] Police Unions - this is off topic
  30. 2020-07-08 Ruben Safir <mrbrklyn-at-panix.com> Subject: [Hangout - NYLXS] State Budget Collapse
  31. 2020-07-09 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] Graphitti is BACK.
  32. 2020-07-09 Ruben Safir <ruben-at-mrbrklyn.com> Re: [Hangout - NYLXS] Graphitti is BACK.
  33. 2020-07-09 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] Biden switching sides..
  34. 2020-07-09 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] QUnatifying the impact of COVID-19 coming into
  35. 2020-07-09 Ruben Safir <ruben-at-mrbrklyn.com> Re: [Hangout - NYLXS] [ Docs ] Israel's second wave
  36. 2020-07-09 Helene Weinstein <weinsteinh-at-nyassembly.gov> Re: [Hangout - NYLXS] Graphitti is BACK.
  37. 2020-07-09 Ruben Safir <ruben-at-mrbrklyn.com> Re: [Hangout - NYLXS] [ Docs ] Israel's second wave
  38. 2020-07-09 mayer ilovitz <pmamayeri-at-gmail.com> Re: [Hangout - NYLXS] [ Docs ] Israel's second wave
  39. 2020-07-10 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] huge scup caught tonight
  40. 2020-07-09 Edgar Hagenbichler <edgar.hagenbichler-at-hagenbichler.at> Subject: [Hangout - NYLXS] [Health] Free Webinar "GNU Health for beginners"
  41. 2020-07-09 From: "American Museum of Natural History" <GilderCenter-at-amnh.org> Subject: [Hangout - NYLXS] Gilder Center Project Update
  42. 2020-07-09 Rabbinical Seminary of America <info-at-rsa30k.com> Subject: [Hangout - NYLXS] THE WINNER OF THE $30,000 SWEEPSTAKES IS...
  43. 2020-07-10 From: "American Museum of Natural History" <email-at-amnh.org> Subject: [Hangout - NYLXS] Today! Manhattanhenge is Back!
  44. 2020-07-10 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] Porgy from Water to Oven
  45. 2020-07-11 ronald munjoma <simbiso-at-gmail.com> Re: [Hangout - NYLXS] [Health] Free Webinar "GNU Health for
  46. 2020-07-11 From: "Pharmacy Times Continuing Education - PTCE" <ptce-at-pharmacytimes.org> Subject: [Hangout - NYLXS] COVID-19 Live Free CE Webinar!
  47. 2020-07-12 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] Bulding a community
  48. 2020-07-13 Gabor Szabo <gabor-at-szabgab.com> Subject: [Hangout - NYLXS] [Perlweekly] #468 - Is Cor the solution?
  49. 2020-07-13 aviva <aviva-at-gmx.us> Re: [Hangout - NYLXS] [ Docs ] Israel's second wave
  50. 2020-07-13 George Moskowitz MD <yehudazev-at-gmail.com> Subject: [Hangout - NYLXS] Fwd: Rabbi Dr. Sacks and my humble thoughts
  51. 2020-07-13 NCPA eCommunications <ncpa.ecommunications-at-ncpanet.org> Subject: [Hangout - NYLXS] =?utf-8?q?NCPA_urges_Florida_not_to_extend_PBM?=
  52. 2020-07-12 Kian Kasad via artix-general <artix-general-at-artixlinux.org> Re: [Hangout - NYLXS] [artix-general] how to create distcc-runit
  53. 2020-07-11 Chris Cromer via artix-general <artix-general-at-artixlinux.org> Re: [Hangout - NYLXS] [artix-general] Software proposal for the cli
  54. 2020-07-09 Javier via artix-general <artix-general-at-artixlinux.org> Subject: [Hangout - NYLXS] [artix-general] [artix-linux][lsb-release]
  55. 2020-07-10 Paolo Giacomel via artix-general <artix-general-at-artixlinux.org> Subject: [Hangout - NYLXS] [artix-general] Software proposal for the cli
  56. 2020-07-13 Ruben Safir <ruben-at-mrbrklyn.com> Re: [Hangout - NYLXS] Fwd: CNN 7/3/20: Twitter and JPMorgan are
  57. 2020-07-13 mayer ilovitz <pmamayeri-at-gmail.com> Re: [Hangout - NYLXS] Fwd: CNN 7/3/20: Twitter and JPMorgan are
  58. 2020-07-13 Ruben Safir <ruben-at-mrbrklyn.com> Re: [Hangout - NYLXS] Fwd: CNN 7/3/20: Twitter and JPMorgan are
  59. 2020-07-13 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] Undermining our Government and Economy
  60. 2020-07-13 Ruben Safir <ruben-at-mrbrklyn.com> Re: [Hangout - NYLXS] [ Docs ] Undermining our Government and
  61. 2020-07-13 Ruben Safir <ruben-at-mrbrklyn.com> Re: [Hangout - NYLXS] [ Docs ] Undermining our Government and
  62. 2020-07-13 Miss Belmar Princess <missbelmar-at-aol.com> Subject: [Hangout - NYLXS] WEEKEND WRAP UP WITH BLUES, SEA BASS & LING!
  63. 2020-07-14 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] fix the dictionary
  64. 2020-07-14 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] COVID-19 and food shortages
  65. 2020-07-14 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] COVID-19 and food shortages II
  66. 2020-07-14 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] COVID-19 and food shortagees III
  67. 2020-07-14 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] COVID-19 and food shortagees IV
  68. 2020-07-14 soledad.esteban <soledad.esteban-at-icp.cat> Subject: [Hangout - NYLXS] [dinosaur] Live Online course: 3D GEOMETRIC
  69. 2020-07-14 soledad.esteban <soledad.esteban-at-icp.cat> Subject: [Hangout - NYLXS] [dinosaur] Live Online course: 3D GEOMETRIC
  70. 2020-07-14 Dudemanguy via artix-general <artix-general-at-artixlinux.org> Re: [Hangout - NYLXS] [artix-general] [s6] system not
  71. 2020-07-14 Javier via artix-general <artix-general-at-artixlinux.org> Re: [Hangout - NYLXS] [artix-general] [s6] system not
  72. 2020-07-13 Dudemanguy via artix-general <artix-general-at-artixlinux.org> Re: [Hangout - NYLXS] [artix-general] [s6] system not
  73. 2020-07-14 From: "John Sullivan, FSF" <info-at-fsf.org> Subject: [Hangout - NYLXS] Your support drives our fight for #UserFreedom
  74. 2020-07-15 IEEE Engineering in Medicine and Biology Society <noreply-at-embs.org> Subject: [Hangout - NYLXS] Changes to the EMB Constitution/Bylaws - Deadline
  75. 2020-07-15 From: =?utf-8?Q?Zo=C3=AB_Kooyman=2C_FSF?= <info-at-fsf.org> Subject: [Hangout - NYLXS] Don't let proprietary digital voting disrupt
  76. 2020-07-16 From: "[RSS/Feed] nixCraft: Linux Tips, Hacks, Tutorials, Subject: [Hangout - NYLXS] nixCraft Linux / UNIX Newsletter
  77. 2020-07-17 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] Fwd: Re: mv w/mkdir -p of destination
  78. 2020-07-17 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] paging Fernando
  79. 2020-07-17 Ruben Safir <mrbrklyn-at-panix.com> Subject: [Hangout - NYLXS] taunting the cops on broadway
  80. 2020-07-19 aviva <aviva-at-gmx.us> Re: [Hangout - NYLXS] [dinosaur] Prehistoric Road Trip, Tiny Teeth,
  81. 2020-07-18 friedmanhvj-at-aol.com Subject: [Hangout - NYLXS] [dinosaur] Prehistoric Road Trip, Tiny Teeth,
  82. 2020-07-19 aviva <aviva-at-gmx.us> Re: [Hangout - NYLXS] [dinosaur] Prehistoric Road Trip, Tiny Teeth,
  83. 2020-07-19 aviva <aviva-at-gmx.us> Re: [Hangout - NYLXS] [dinosaur] Prehistoric Road Trip, Tiny Teeth,
  84. 2020-07-18 Thomas Richard Holtz <tholtz-at-umd.edu> Re: [Hangout - NYLXS] [dinosaur] Prehistoric Road Trip, Tiny Teeth,
  85. 2020-07-18 aviva <aviva-at-gmx.us> Re: [Hangout - NYLXS] [dinosaur] Prehistoric Road Trip, Tiny Teeth,
  86. 2020-07-18 aviva <aviva-at-gmx.us> Subject: [Hangout - NYLXS] [dinosaur] Prehistoric Road Trip, Tiny Teeth,
  87. 2020-07-18 aviva <aviva-at-gmx.us> Subject: [Hangout - NYLXS] [dinosaur] Prehistoric Road Trip, Tiny Teeth,
  88. 2020-07-20 Gabor Szabo <gabor-at-szabgab.com> Subject: [Hangout - NYLXS] [Perlweekly] #469 - United Perl Mongers
  89. 2020-07-20 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] time to fire this guy
  90. 2020-07-20 From: "American Museum of Natural History" <email-at-amnh.org> Subject: [Hangout - NYLXS] Online resources to explore with your students
  91. 2020-07-20 ronald munjoma <simbiso-at-gmail.com> Re: [Hangout - NYLXS] [Health] webinar GNUHealth for beginners on
  92. 2020-07-20 Thomas Richard Holtz <tholtz-at-umd.edu> Re: [Hangout - NYLXS] [dinosaur] Prehistoric Road Trip, Tiny Teeth,
  93. 2020-07-20 aviva <aviva-at-gmx.us> Re: [Hangout - NYLXS] [dinosaur] Prehistoric Road Trip, Tiny Teeth,
  94. 2020-07-20 aviva <aviva-at-gmx.us> Re: [Hangout - NYLXS] [dinosaur] Prehistoric Road Trip, Tiny Teeth,
  95. 2020-07-20 Anthony <keenir-at-hotmail.com> Re: [Hangout - NYLXS] [dinosaur] Prehistoric Road Trip, Tiny Teeth,
  96. 2020-07-20 Mike Habib <biologyinmotion-at-gmail.com> Re: [Hangout - NYLXS] [dinosaur] Prehistoric Road Trip, Tiny Teeth,
  97. 2020-07-20 Liz M <egmartin19-at-gmail.com> Re: [Hangout - NYLXS] [dinosaur] Prehistoric Road Trip, Tiny Teeth,
  98. 2020-07-20 Ruben Safir <ruben-at-mrbrklyn.com> Re: [Hangout - NYLXS] [dinosaur] Prehistoric Road Trip, Tiny Teeth,
  99. 2020-07-20 From: "PSSNY" <staff-at-pssny.org> Subject: [Hangout - NYLXS] =?utf-8?q?Urge_Legislature_to_Pass_the_PBM_bil?=
  100. 2020-07-20 Yusif Suleiman <yusifsuleiman-at-hotmail.com> Re: [Hangout - NYLXS] [Health] webinar GNUHealth for beginners on
  101. 2020-07-21 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] Pork PreCovid analysis - maybe
  102. 2020-07-21 aviva <aviva-at-gmx.us> Subject: [Hangout - NYLXS] anyone ever deal with the Dinosaur mailing list?
  103. 2020-07-22 Ruben Safir <ruben-at-mrbrklyn.com> Re: [Hangout - NYLXS] [ Docs ] anyone ever deal with the Dinosaur
  104. 2020-07-22 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] strange cd behaviorn
  105. 2020-07-22 Luis Falcon <falcon-at-gnuhealth.org> Re: [Hangout - NYLXS] [Health] webinar GNUHealth for beginners on
  106. 2020-07-22 Edgar Hagenbichler <edgar.hagenbichler-at-hagenbichler.at> Subject: [Hangout - NYLXS] [Health] webinar GNUHealth for beginners on Mon 3
  107. 2020-07-23 From: "American Museum of Natural History" <learn-at-amnh.org> Subject: [Hangout - NYLXS] Registration Is Now Open for Our First Fall
  108. 2020-07-23 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] A Message from President Kimberly R. Cline
  109. 2020-07-23 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] Informational Message: Certified Pharmacist
  110. 2020-07-27 Gabor Szabo <gabor-at-szabgab.com> Subject: [Hangout - NYLXS] [Perlweekly] #470 - Perl Mentoring
  111. 2020-07-26 The Hebron Fund <info-at-hebronfund.org> Subject: [Hangout - NYLXS] Hero Soldier, Life After Corona VIDEO,
  112. 2020-07-27 Gabor Szabo <gabor-at-szabgab.com> Subject: [Hangout - NYLXS] [Perlweekly] #470 - Perl Mentoring
  113. 2020-07-27 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] Belmar vacation - One Sunday
  114. 2020-07-27 Steffen Land <info-at-apachelounge.com.INVALID> Re: [Hangout - NYLXS] [users-at-httpd] Announcing mod_websocket v0.1.2
  115. 2020-07-28 From: "Dana Morgenstein, FSF" <info-at-fsf.org> Subject: [Hangout - NYLXS] Presenting the expanded Free Software Foundation
  116. 2020-07-28 jerome moliere via artix-general <artix-general-at-artixlinux.org> Subject: [Hangout - NYLXS] [artix-general] Newcomer - a couple of questions
  117. 2020-07-28 Christos Nouskas via artix-general <artix-general-at-artixlinux.org> Re: [Hangout - NYLXS] [artix-general] Newcomer - a couple of
  118. 2020-07-29 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] Virus cases in Israel - Do we trust the experts..
  119. 2020-07-30 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] Tish B'av
  120. 2020-07-30 From: "American Museum of Natural History" <learn-at-amnh.org> Subject: [Hangout - NYLXS] Learn More About Our Online Courses for Teachers
  121. 2020-07-30 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] Herman cain died of WUHAN-19
  122. 2020-07-30 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] fre the mind
  123. 2020-07-30 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] Bounces City and State checks...
  124. 2020-07-30 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] No end to the medical ethics problems we now
  125. 2020-07-30 Mark Galassi <mark-at-galassi.org> Subject: [Hangout - NYLXS] looking for collaborators for free s/w-based
  126. 2020-07-30 From: =?utf-8?Q?Zo=C3=AB_Kooyman=2C_FSF?= <info-at-fsf.org> Subject: [Hangout - NYLXS] Free software in business: Success stories
  127. 2020-07-31 zap via artix-general <artix-general-at-artixlinux.org> Subject: [Hangout - NYLXS] [artix-general] I had a suggestion or two,
  128. 2020-07-31 zap via artix-general <artix-general-at-artixlinux.org> Subject: [Hangout - NYLXS] [artix-general] I had a suggestion or two,
  129. 2020-07-31 zap via artix-general <artix-general-at-artixlinux.org> Subject: [Hangout - NYLXS] [artix-general] I had a suggestion or two,
  130. 2020-07-13 mayer ilovitz <pmamayeri-at-gmail.com> Re: [Hangout - NYLXS] Fwd: CNN 7/3/20: Twitter and JPMorgan are
  131. 2020-07-13 mayer ilovitz <pmamayeri-at-gmail.com> Subject: [Hangout - NYLXS] Fwd: CNN 7/3/20: Twitter and JPMorgan are

NYLXS are Do'ers and the first step of Doing is Joining! Join NYLXS and make a difference in your community today!